These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35133575)

  • 1. Efficacy of novel agents in patients with nephropathy associated with POEMS syndrome.
    Cheng S; Huang L; Fan W; Liang D; Zhu X; Jiang S; Ge Y
    Int Urol Nephrol; 2022 Sep; 54(9):2317-2325. PubMed ID: 35133575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of POEMS syndrome with lenalidomide and dexamethasone].
    Goto A; Iyama S; Sugama Y; Yoshida M; Ibata S; Tatekoshi A; Fujita C; Kikuchi S; Ikeda H; Murase K; Takada K; Kato J; Kobune M
    Rinsho Ketsueki; 2019; 60(4):308-313. PubMed ID: 31068561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lenalidomide Treatment for Thalidomide-refractory POEMS Syndrome: A Prospective Single-arm Clinical Trial.
    Suichi T; Misawa S; Nagashima K; Sato Y; Iwai Y; Katayama K; Sekiguchi Y; Shibuya K; Amino H; Suzuki YI; Tsuneyama A; Nakamura K; Kuwabara S
    Intern Med; 2020 May; 59(9):1149-1153. PubMed ID: 32009091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of sexual function in POEMS syndrome after combination therapy of Lenalidomide and dexamethasone.
    Yang H; Huang X; Cai Q; Wang C; Cao X; Zhou D; Li J
    Orphanet J Rare Dis; 2016 Jun; 11(1):80. PubMed ID: 27317315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lenalidomide and dexamethasone in patients with POEMS syndrome: results of a prospective, open-label trial.
    Nozza A; Terenghi F; Gallia F; Adami F; Briani C; Merlini G; Giordano L; Santoro A; Nobile-Orazio E
    Br J Haematol; 2017 Dec; 179(5):748-755. PubMed ID: 29048107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin Responses in Newly Diagnosed Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes (POEMS) Syndrome After Therapy With Low-Dose Lenalidomide Plus Dexamethasone.
    Gao Y; Zhang S; Yang L; Li J; Liu Y; Wang T
    Front Immunol; 2021; 12():681360. PubMed ID: 34025681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A spectrum of clinicopathological features of nephropathy associated with POEMS syndrome.
    Nakamoto Y; Imai H; Yasuda T; Wakui H; Miura AB
    Nephrol Dial Transplant; 1999 Oct; 14(10):2370-8. PubMed ID: 10528660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of lenalidomide in POEMS syndrome: a retrospective study of 20 patients.
    Royer B; Merlusca L; Abraham J; Musset L; Haroche J; Choquet S; Leleu X; Sebban C; Decaux O; Galicier L; Roussel M; Recher C; Banos A; Guichard I; Brisseau JM; Godmer P; Hermine O; Deplanque G; Facon T; Asli B; Leblond V; Fermand JP; Marolleau JP; Jaccard A
    Am J Hematol; 2013 Mar; 88(3):207-12. PubMed ID: 23335406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. POEMS syndrome with undetectable M-protein: a case report and literature review.
    Xue HY; Zhou L; Yuan QZ; Zhang Y; Hao YQ; Chen SW; Wang HK; Wei F
    Diagn Pathol; 2024 Jun; 19(1):74. PubMed ID: 38849857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bortezomib plus dexamethasone as first-line therapy for patients with POEMS syndrome.
    Gao XM; Yu YY; Zhao H; Cai H; Zhang L; Cao XX; Zhou DB; Li J
    Ann Hematol; 2021 Nov; 100(11):2755-2761. PubMed ID: 34331562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial.
    Misawa S; Sato Y; Katayama K; Nagashima K; Aoyagi R; Sekiguchi Y; Sobue G; Koike H; Yabe I; Sasaki H; Watanabe O; Takashima H; Nishizawa M; Kawachi I; Kusunoki S; Mitsui Y; Kikuchi S; Nakashima I; Ikeda S; Kohara N; Kanda T; Kira J; Hanaoka H; Kuwabara S;
    Lancet Neurol; 2016 Oct; 15(11):1129-37. PubMed ID: 27496680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thalidomide reduces serum VEGF levels and improves peripheral neuropathy in POEMS syndrome.
    Kuwabara S; Misawa S; Kanai K; Sawai S; Hattori T; Nishimura M; Nakaseko C
    J Neurol Neurosurg Psychiatry; 2008 Nov; 79(11):1255-7. PubMed ID: 18469028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of POEMS syndrome complicated by severe congestive heart failure with thalidomide.
    Inoue D; Kato A; Tabata S; Kitai T; Takiuchi Y; Kimura T; Shimoji S; Mori M; Nagai Y; Togami K; Matsushita A; Nagai K; Maruoka H; Imai Y; Beppu M; Kawamoto M; Takahashi T
    Intern Med; 2010; 49(5):461-6. PubMed ID: 20190484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of thyroid function in POEMS syndrome after combination therapy of lenalidomide and dexamethasone.
    Yang H; Zhao H; Huang X; Cao X; Zhou D; Li J
    Leuk Lymphoma; 2019 Feb; 60(2):483-487. PubMed ID: 30407096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of low-dose lenalidomide plus dexamethasone in patients with relapsed or refractory POEMS syndrome.
    Cai QQ; Wang C; Cao XX; Cai H; Zhou DB; Li J
    Eur J Haematol; 2015 Oct; 95(4):325-30. PubMed ID: 25401269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined Therapy with Ixazomib, Lenalidomide, and Dexamethasone for Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome.
    Suichi T; Misawa S; Sekiguchi Y; Shibuya K; Nakamura K; Kano H; Aotsuka Y; Otani R; Morooka M; Tsukamoto S; Takeda Y; Mimura N; Ohwada C; Sakaida E; Kuwabara S
    Intern Med; 2022; 61(17):2567-2572. PubMed ID: 36047093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Successful treatment of POEMS syndrome-associated pulmonary hypertension with lenalidomide and dexamethasone therapy].
    Nakamura D; Hayashida M; Kubota K; Matsuura E; Tabuchi T; Arima N; Inoue H; Yoshimitsu M; Ishitsuka K
    Rinsho Ketsueki; 2018; 59(5):489-491. PubMed ID: 29877235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daratumumab plus lenalidomide and dexamethasone for relapsed POEMS syndrome with bone plasmacytoma harboring 17p deletion.
    Oyama T; Taoka K; Chiba A; Masamoto Y; Ikemura M; Honda A; Maki H; Kurokawa M
    Int J Hematol; 2023 Mar; 117(3):463-467. PubMed ID: 36202948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effective treatment of POEMS syndrome accompanied by plasmacytoma with lenalidomide, dexamethasone, and local irradiation].
    Takahashi W; Ichikawa M; Okazaki A; Nakamura F; Arai H; Handa T; Nakamura Y; Nakamura Y; Seo S; Sasaki K; Mitani K
    Rinsho Ketsueki; 2020; 61(3):262-267. PubMed ID: 32224588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OCULAR MANIFESTATIONS AND TREATMENT OUTCOMES IN CHINESE PATIENTS WITH POEMS SYNDROME.
    Zhang X; Cai QQ; Huang XF; Cao XX; Cai H; Zhou DB; Dai RP; Li J
    Retina; 2017 Sep; 37(9):1784-1791. PubMed ID: 27930460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.